Showing results (41-50 of 570) with videos related to
Sort By:
Pageof 57
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinomaB G Redman, Y Abubakr, T Chou, et al.Cancer Research|August 1, 1987
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Self-boosting vaccines and their implications for herd immunityNimalan Arinaminpathy, Jennie S Lavine, Bryan T GrenfellScience (New York, N.Y.)|January 13, 2021
Immunological characteristics govern the transition of COVID-19 to endemicityJennie S Lavine, Ottar N Bjornstad, Rustom AntiaImmunogenetics|January 1, 1982
Syngeneic tumor immunizations produce Qa antibodies. Discovery of a new Qa antigen, Qa-6L Flaherty, M Karl, C L ReinischThe Cancer Journal From Scientific American|February 24, 2000
Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2K Shimizu, R C Fields, B G Redman, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1978
Qa-2 and Qa-3 antigens on lymphocyte subpopulations. I. Mitogen responsivenessL Flaherty, D Zimmerman, K A SullivanEuropean Journal of Immunology|February 1, 1982
Polymorphism of a Qa-1-associated antigen defined by cytotoxic T cells. I. Qed-1a and Qed-1dK F Lindahl, B Hausmann, L FlahertyCritical Pathways in Cardiology|August 2, 2007
Critical pathways for the management of stroke and intracerebral hemorrhage: a survey of US hospitalsDavid Cooper, Edward Jauch, Matthew L FlahertyThe Journal of Experimental Medicine|July 1, 1979
Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodiesG J Hämmerling, U Hämmerling, L FlahertyPageof 57